Morgan Stanley Edesa Biotech, Inc. Transaction History

Morgan Stanley

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$0.63 - $0.99 $126 - $198	200 New	200 $0
Q4 2022 Feb 14, 2023	BUY	$0.8 - $8.05 $144 - $1,449	180 Added 15.11%	1,371 $2,000
Q1 2022 May 13, 2022	SELL	$2.72 - $5.97 $745 - $1,635	-274 Reduced 18.7%	1,191 $4,000
Q4 2021 Feb 14, 2022	BUY	$5.17 - $8.65 $6,540 - $10,942	1,265 Added 632.5%	1,465 $8,000
Q3 2021 Nov 15, 2021	BUY	$4.2 - $11.92 $840 - $2,384	200 New	200 $1,000

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.